Australian experience supports novel haemostatic agent efficacy in AHA

An Australian case series of six bleeds from four patients with acquired haemophilia A has provided further evidence to support the efficacy of recombinant porcine factor VIII (rpFVIII, Obizur) to treat bleeding in the condition. Dr Sally Campbell of the Australian Centre for Blood Diseases, Monash University published the reports in the Internal Medicine Journal, showing that rpFVIII ...

Already a member?

Login to keep reading.

© 2021 the limbic